| Title | [Complete remission after Rituximab treatment in refractory hairy cell leukemia.] | | Author(s) | Petruskevicius I, Bukh A, Mertz H, Johnsen HE | | Institution | Hæmatologisk Afdeling, Medicinerhuset, Mølleparkvej 4, Postboks 561, DK-9100 Aalborg. irp@rn.dk. | | Source | Ugeskr Laeger 2008 Jun 23; 170(26):2350. | | Abstract | A 40 year-old man with hairy cell leukemia (HCL) was treated with Cladribin, but achieved only partial response (PR). As expected, both 2 and 5 years later the disease had progressed and the patient was therefore twice retreated with Cladribin. A bone marrow examination after the last Cladribin course showed complete response with residual disease (CR-RD). The patient received consolidation therapy with Rituximab, achieved complete response (CR) and was still in CR 9 months later. Rituximab is a good treatment option for patients with refractory HCL because of its significant activity and minimal toxicity. | | Language | DAN | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18570771 |
|
